Lao People's Democratic Republic vs Mali: Average cost of multi drug-resistant tuberculosis treatment
Lao People's Democratic Republic
756 constant 2022 US$
in 2024
Mali
709 constant 2022 US$
in 2024
Lao People's Democratic Republic rank
64th
Mali rank
67th
Average cost of multi drug-resistant tuberculosis treatment over time
- Lao People's Democratic Republic
- Mali
How they compare
Lao People's Democratic Republic currently reports 756 constant 2022 US$ against 709 constant 2022 US$ in Mali, a difference of 47 constant 2022 US$.
That makes Lao People's Democratic Republic's figure about 1.1 times Mali's.
The two have swapped places 1 time across 7 shared years of data; in 2017 it was Mali ahead.
Lao People's Democratic Republic ranks 64th and Mali ranks 67th of 92 countries.
Mali has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,322 constant 2022 US$ | 5,465 constant 2022 US$ | 4,143 constant 2022 US$ | Mali |
| 2020s | 939 constant 2022 US$ | 18,173 constant 2022 US$ | 17,234 constant 2022 US$ | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Lao People's Democratic Republic or Mali?
- Lao People's Democratic Republic, at 756 constant 2022 US$ against 709 constant 2022 US$ in Mali as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Lao People's Democratic Republic and Mali?
- 47 constant 2022 US$, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Mali?
- 7 years are reported by both, from 2017 to 2024.
- How do Lao People's Democratic Republic and Mali rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Lao People's Democratic Republic ranks 64th and Mali ranks 67th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.